Akèy › Kansè (tout kalite) › New York › Buffalo
Etid klinik pou Kansè (tout kalite) nan Buffalo, NY
19 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Buffalo (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of ASP3082 in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
- Roswell Park Cancer Institute, Buffalo
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Ap rekriteFaz 3
- Quetzal Site 4, Buffalo
Intratumoral N17350 in Advanced Solid Tumors
Ap rekriteFaz 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Ap rekriteEtid obsèvasyon
- Roswell Park Comprehensive Cancer Center, Buffalo
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- Roswell Park Cancer Institute, Buffalo
Collection of Tissue Samples for Cancer Research
Ap rekriteEtid obsèvasyon
- Roswell Park Cancer Institute, Buffalo
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
- Roswell Park Center Institute, Buffalo
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Roswell Park Cancer Institute, Buffalo
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Ap rekriteFaz 1
- Roswell Park Cancer Institute, Buffalo
Childhood Cancer Survivor Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Roswell Park Cancer Institute, Buffalo
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Ap rekriteFaz 1
- Roswell Cancer Institute, Buffalo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Roswell Park Cancer Institute, Buffalo
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Ap rekriteFaz 1
- Roswell Park, Buffalo
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Ap rekriteFaz 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
Ap rekrite
- University at Buffalo / Great Lakes Cancer Care, Buffalo
Cannabis Use and Outcomes in Black and White Patients With Cancer
Ap rekriteEtid obsèvasyon
- University at Buffalo, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Buffalo
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Ap rekrite
- Roswell Park Cancer Institute, Buffalo
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Ap rekriteFaz 1/2
- Roswell Park Cancer Institute, Buffalo
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA85 etid
- Los Angeles, CA74 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC58 etid
- Durham, NC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
Lòt etid nan Buffalo
- Kansè Poumon ki pa ti selil19 etid
- Leksemi mieloïd egi19 etid
- Kansè poumon16 etid
- Kansè nan tete16 etid
- Kansè ovè13 etid
- Kansè Metastatik11 etid
- Kansè pwostat11 etid
- Melanom10 etid
- Myelom Miltip10 etid
- Obèsite9 etid
- Limfòm Burkitt8 etid
- Sendwòm myelodisplastik8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.